Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

Summary

The present study is a pilot clinical trial using personalized neoantigen peptide vaccines with the addition of Leukine (Sargramostim), in patients with different types of cancer.

Timeline

Start

2022-05-12

Primary completion

2025-11-25

Completion

2026-06-20

Drugs

Indications